2026 NPPES data Oral and Maxillofacial Pathology Dentistry NPI 1700869765 D.D.S.
Verify on CMS →

ROBERT LICUL, D.D.S.

Oral and Maxillofacial Pathology Dentistry in WESTBURY, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
644
Medicare Part D claims · 230 beneficiaries · Oral and Maxillofacial Pathology Dentistry avg: 303
Industry payments
$96.83
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ROBERT LICUL, D.D.S. is a Oral and Maxillofacial Pathology Dentistry ([object Object]) practicing in WESTBURY, New York with a Medicare Part D prescribing footprint of 644 claims across 230 beneficiaries . Industry payments of $96.83 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ROBERT LICUL, D.D.S. filed 644 Medicare Part D claims in 2023 across WESTBURY, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

ROBERT LICUL, D.D.S. at a glance

Quality data not reported

NPI registry status

Active

Issued 11/23/2005

NPI 1700869765

Primary specialty

Oral and Maxillofacial Pathology Dentistry

Niche

690 US NPIs in this specialty

Medicare Part D claims

644 113% vs specialty avg

2023 prescription claims

Specialty avg: 303

Specialty distribution in New York

How Oral and Maxillofacial Pathology Dentistry compares to other specialties among New York providers

New York providers

Oral and Maxillofacial Pathology Dentistry share within New York

1. Oral and Maxillofacial Pathology Dentistry42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Oral and Maxillofacial Pathology Dentistry share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Oral and Maxillofacial Pathology Dentistry (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Oral and Maxillofacial Pathology Dentistry ABMS/AOA estimate

Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Oral and Maxillofacial Pathology Dentistry) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT LICUL, D.D.S. is a Oral and Maxillofacial Pathology Dentistry provider practicing in WESTBURY, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.D.S.. NPI: 1700869765. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ROBERT LICUL, D.D.S. appears in the CMS NPPES registry as a Oral and Maxillofacial Pathology Dentistry provider holding D.D.S. credentials at 959 BRUSH HOLLOW RD, WESTBURY, NY, 11590, with a listed phone of (516) 333-5900. NPI 1700869765 was issued on 11/23/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LICUL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 644 prescription claims written by this provider, covering 230 Medicare beneficiaries and totaling roughly $3K in drug spend, with an opioid prescribing rate of 32.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Oral and Maxillofacial Pathology Dentistry is a narrow specialty nationwide, with 690 enrolled providers across 48 states and an average of 303 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

959 BRUSH HOLLOW RD
WESTBURY, NY 11590

Provider Details

NPI 1700869765
Specialty Oral and Maxillofacial Pathology Dentistry
Credentials D.D.S.
Gender Male
NPI Issued 11/23/2005

Hospital and facility affiliations

Facilities where ROBERT LICUL, D.D.S. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LONG ISLAND ORAL SURGERY ASSOCIATES
SYOSSET, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT LICUL, D.D.S.. Source: openpaymentsdata.cms.gov.

Total received

$97

Largest payer

Dentsply Sirona Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ROBERT LICUL, D.D.S.. To verify ROBERT LICUL, D.D.S.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

644
Total Claims
$3K
Total Drug Cost
230
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
644
Total Day Supply
4,901
Generic Drug Cost
$3K
Opioid Claims
206 (32.0% rate)
Antibiotic Claims
277

Patient Demographics

Average Patient Age
75.7 years
Avg HCC Risk Score
1.01
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Amoxicillin
204
Chlorhexidine Gluconate
149
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
132
Acetaminophen-Codeine
Acetaminophen With Codeine
70
Clindamycin Hcl
48
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Oral and Maxillofacial Pathology Dentistry Overview

How ROBERT LICUL, D.D.S. fits within the Oral and Maxillofacial Pathology Dentistry landscape nationally.

690
Oral and Maxillofacial Pathology Dentistry Providers in US
48
States with Oral and Maxillofacial Pathology Dentistry
303
Avg Claims per Provider

ROBERT LICUL, D.D.S.'s 644 claims are above the specialty average of 303.

Nearby Oral and Maxillofacial Pathology Dentistry Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as LICUL.

Compare Oral and Maxillofacial Pathology Dentistry nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT LICUL, D.D.S.'s specialty?
ROBERT LICUL, D.D.S. specializes in Oral and Maxillofacial Pathology Dentistry and practices in WESTBURY, New York. Credentials: D.D.S..
How much does ROBERT LICUL, D.D.S. prescribe under Medicare Part D?
In 2023, ROBERT LICUL, D.D.S. wrote 644 Medicare Part D claims totaling $3K in drug costs for 230 beneficiaries.
Where is ROBERT LICUL, D.D.S. located?
ROBERT LICUL, D.D.S. is located at 959 BRUSH HOLLOW RD, WESTBURY, NY, 11590. Phone: (516) 333-5900.
What is ROBERT LICUL, D.D.S.'s NPI number?
ROBERT LICUL, D.D.S.'s National Provider Identifier (NPI) is 1700869765, issued on 11/23/2005.
Does ROBERT LICUL, D.D.S. prescribe opioids?
Yes, ROBERT LICUL, D.D.S. had 206 opioid claims in 2023 with an opioid prescribing rate of 32.0%.
How many Oral and Maxillofacial Pathology Dentistry providers are there in the US?
There are 690 Oral and Maxillofacial Pathology Dentistry providers across 48 states in the US. The average Oral and Maxillofacial Pathology Dentistry provider writes 303 Medicare Part D claims per year.
What drugs does ROBERT LICUL, D.D.S. prescribe most often?
Based on 2023 Medicare Part D data, ROBERT LICUL, D.D.S.'s most frequently prescribed drugs include Amoxicillin, Chlorhexidine Gluconate, Oxycodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT LICUL, D.D.S. accept Medicare?
ROBERT LICUL, D.D.S. appears in CMS Medicare data with 644 Part D claims and 230 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT LICUL, D.D.S.'s credentials?
ROBERT LICUL, D.D.S.'s NPI is 1700869765 with credentials D.D.S.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology